Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation
Clinical trial NCT01516983 · COMPLETED
Trial details
- NCT number
- NCT01516983
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2013-06-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.